Effect of Omega 3 Fats on Sperm Quality and Sexual Function

Sponsor
Reproductive Partners Medical Group (Other)
Overall Status
Terminated
CT.gov ID
NCT00406874
Collaborator
(none)
6
1
11
0.5

Study Details

Study Description

Brief Summary

This study compares the effects of omega 3 fats plus folic acid with placebo plus folic acid on sperm quality and sexual function in infertile men. It will also evaluate the effects on sexual fuction of a sub-therapeutic dose of a PDE 5 inhibitor versus placebo in subjects continuing on both omega 3 fats and folic acid.

Condition or Disease Intervention/Treatment Phase
  • Drug: omega 3 fats
  • Drug: folic acid
Phase 2

Detailed Description

Infertile men commonly have difficulty timing sexual relations around the time of ovulation. There is a high incidence of abnormal sperm morphology in infertile men. Omega 3 fats are known to increase the production of nitric oxide, which is the mediator of the male response, and folic acid is an important cofactor in the production of nitric oxide. Omega 3 fats are also important in the structure and function of cell membranes. There is a high incidence of deficient intake of omega 3 fats and folic acid in the U.S. population. Both folic acid and omega 3 fats are available as nutritional supplements and the doses used in this study are doses commonly recommended as nutritional supplements.

Comparison: Omega 3 fats plus folic acid will be compared with placebo plus folic acid in men age 35 to 55 attempting pregnancy with normal or mildly impaired semen quality. They will fill out dietary questionaires, questionaires regarding sexual function, and will have measurements of serum nitrates, blood pressure, and semen quality before and during use of these nutritional supplements. In men continuing on both omega 3 fats and folic acid, we will compare the effects of a sub-therapeutic dose of a PDE 5 inhibitor versus placebo on their sexual function.

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Omega 3 Fats on Sperm Quality and Sexual Function in Infertile Men Age 35-55
Study Start Date :
Jan 1, 2007
Actual Primary Completion Date :
Dec 1, 2007
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Questionaires regarding sexual function [every 30 days]

  2. Semen analysis [every 30 days]

Secondary Outcome Measures

  1. blood pressure [every 30 days]

  2. serum nitrate levels [every 30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 55 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • infertile men

  • age 35 to 55

  • expressing difficulty timing relations to their partner's ovulation

Exclusion Criteria:
  • hypertension, heart disease or other systemic diseases

  • fatty fish intake more than twice per week

  • marked semen abnormalities (less than 10 million sperm per ml, less than 20 % A plus B motility, more than 1 million WBC per HPF)

  • use of anticoagulants

  • must be willing to not take PDE 5 inhibitors during the study

  • use of other supplements is prohibited during the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Reproductive Partners medical Group Redondo beach California United States 90277

Sponsors and Collaborators

  • Reproductive Partners Medical Group

Investigators

  • Principal Investigator: David R Meldrum, M.D., Reproductive Partners Medical Group

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David R. Meldrum, M.D., Scientific Director, Reproductive Partners Medical Group
ClinicalTrials.gov Identifier:
NCT00406874
Other Study ID Numbers:
  • RPMG-1
First Posted:
Dec 4, 2006
Last Update Posted:
Jun 4, 2013
Last Verified:
Jun 1, 2013
Keywords provided by David R. Meldrum, M.D., Scientific Director, Reproductive Partners Medical Group
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2013